183 related articles for article (PubMed ID: 6804496)
21. The binding of factor IXa to cultured bovine aortic endothelial cells. Induction of a specific site in the presence of factors VIII and X.
Stern DM; Nawroth PP; Kisiel W; Vehar G; Esmon CT
J Biol Chem; 1985 Jun; 260(11):6717-22. PubMed ID: 3922979
[TBL] [Abstract][Full Text] [Related]
22. Assembly of the intrinsic factor X activating complex--interactions between factor IXa, factor VIIIa and phospholipid.
van Dieijen G; van Rijn JL; Govers-Riemslag JW; Hemker HC; Rosing J
Thromb Haemost; 1985 Jun; 53(3):396-400. PubMed ID: 3931288
[TBL] [Abstract][Full Text] [Related]
23. A monoclonal antibody to factor IX that inhibits the factor VIII:Ca potentiation of factor X activation.
Bajaj SP; Rapaport SI; Maki SL
J Biol Chem; 1985 Sep; 260(21):11574-80. PubMed ID: 3930478
[TBL] [Abstract][Full Text] [Related]
24. Kinetic studies of the activation of factor X by factors IXa and VIII:C in the absence of thrombin.
Neal GG; Esnouf MP
Br J Haematol; 1984 May; 57(1):123-31. PubMed ID: 6426496
[TBL] [Abstract][Full Text] [Related]
25. The functional defect of factor VIII Leiden, a genetic variant of coagulation factor VIII.
Mertens K; van Wijngaarden A; Bertina RM; Veltkamp JJ
Thromb Haemost; 1985 Oct; 54(3):650-3. PubMed ID: 3937262
[TBL] [Abstract][Full Text] [Related]
26. Formation of a serine enzyme in the presence of bovine factor VIII (antihemophilic factor) and thrombin.
Vehar GA; Davie EW
Science; 1977 Jul; 197(4301):374-6. PubMed ID: 877560
[TBL] [Abstract][Full Text] [Related]
27. Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactor.
Repke D; Gemmell CH; Guha A; Turitto VT; Broze GJ; Nemerson Y
Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7623-7. PubMed ID: 2120704
[TBL] [Abstract][Full Text] [Related]
28. Activation of human factor VII by activated factors IX and X.
Masys DR; Bajaj SP; Rapaport SI
Blood; 1982 Nov; 60(5):1143-50. PubMed ID: 7126868
[TBL] [Abstract][Full Text] [Related]
29. Measurement of human factor IXa activity in an isolated factor X activation system.
Griffith MJ; Reisner HM; Lundblad RL; Roberts HR
Thromb Res; 1982 Aug; 27(3):289-301. PubMed ID: 6814005
[TBL] [Abstract][Full Text] [Related]
30. Functional difference between intrinsic and extrinsic coagulation pathways. Kinetics of factor X activation on human monocytes and alveolar macrophages.
McGee MP; Li LC
J Biol Chem; 1991 May; 266(13):8079-85. PubMed ID: 1902470
[TBL] [Abstract][Full Text] [Related]
31. Platelet heterogeneity: variation in coagulation complexes on platelet subpopulations.
Kempton CL; Hoffman M; Roberts HR; Monroe DM
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):861-6. PubMed ID: 15653564
[TBL] [Abstract][Full Text] [Related]
32. Activation of factor VIII by factor IXa.
Rick ME
Blood; 1982 Sep; 60(3):744-51. PubMed ID: 6809077
[TBL] [Abstract][Full Text] [Related]
33. Two subpopulations of thrombin-activated platelets differ in their binding of the components of the intrinsic factor X-activating complex.
Panteleev MA; Ananyeva NM; Greco NJ; Ataullakhanov FI; Saenko EL
J Thromb Haemost; 2005 Nov; 3(11):2545-53. PubMed ID: 16241952
[TBL] [Abstract][Full Text] [Related]
34. Dibucaine elicits platelet procoagulant activity in factor VIII and factor X activation by a mechanism involving a sulfhydryl-dependent enzyme.
Hultin MB; Hennessey J; Morrison SA
Thromb Res; 1992 Dec; 68(4-5):399-407. PubMed ID: 1290168
[TBL] [Abstract][Full Text] [Related]
35. A Glu113Ala mutation within a factor VIII Ca2+-binding site enhances cofactor interactions in factor Xase.
Wakabayashi H; Su YC; Ahmad SS; Walsh PN; Fay PJ
Biochemistry; 2005 Aug; 44(30):10298-304. PubMed ID: 16042406
[TBL] [Abstract][Full Text] [Related]
36. The kinetic assembly of the intrinsic bovine factor X activation system.
Beals JM; Chibber BA; Castellino FJ
Arch Biochem Biophys; 1989 Feb; 268(2):485-501. PubMed ID: 2492418
[TBL] [Abstract][Full Text] [Related]
37. Kinetics of factor VIII light-chain cleavage by thrombin and factor Xa. A regulatory role of the factor VIII heavy-chain region Lys713-Arg740.
Donath MJ; Lenting PJ; Van Mourik JA; Mertens K
Eur J Biochem; 1996 Sep; 240(2):365-72. PubMed ID: 8841400
[TBL] [Abstract][Full Text] [Related]
38. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
Lämmle B; Griffin JH
Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
[TBL] [Abstract][Full Text] [Related]
39. The activation of human blood coagulation factor X on the surface of endothelial cells: a comparison with various vascular cells, platelets and monocytes.
Brinkman HJ; Mertens K; Holthuis J; Zwart-Huinink LA; Grijm K; van Mourik JA
Br J Haematol; 1994 Jun; 87(2):332-42. PubMed ID: 7947276
[TBL] [Abstract][Full Text] [Related]
40. Formation and functioning of the factor IXa-VIII complex on the surface of endothelial cells.
Váradi K; Elödi S
Blood; 1987 Feb; 69(2):442-5. PubMed ID: 3099860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
